Research Article

RETRACTED - Cell transcription dependent on Wingless-type (Wnt)/beta-catenin in the rat estrous cycle stages

Volume: 10 Number: 6 November 4, 2024
EN

RETRACTED - Cell transcription dependent on Wingless-type (Wnt)/beta-catenin in the rat estrous cycle stages

Abstract

Objectives: We aimed to evaluate how T Cell Factor 7 Like 2 (TCF7L2) and Lymphoid Enhancer Factor-1 (LEF-1), which regulate cell transcription, regulate implantation in the endometrium.

Methods: Female rats were determined according to the estrous cycle. The obtained uterine tissues were taken for immunofluorescence staining.

Results: In estrous, LEF-1 and TCF7L2 showed localization in perimetrial-myometrial connective tissue. Of all the signaling molecules, the TCF7L2 molecule is the only one that is expressed. Non-expressed TCF7L2 in the uterine epithelium showed strong immunolocalization in the perimetrial myometrial connective tissue and endometrial basal stroma area. LEF-1 was mostly expressed in the metaestrus phase in the areas of gland epithelium.

Conclusions: TCF7L2 and LEF-1 play a critical role in cell proliferation, differentiation and transcription by regulating the activation of the Wnt signaling pathway in endometrial cells. These findings help us to understand the role of TCF7L2 and LEF-1 in the provision of endometrial homeostasis and in the implantation process.

Keywords

References

  1. 1. Kaloğlu C, Gürsoy E, Onarlioğlu B. Early maternal changes contributing to the formation of the chorioallantoic and yolk sac placentas in rat: a morphological study. Anat Histol Embryol. 2003;32(4):200-206. doi: 10.1046/j.1439-0264.2003.00450.x.
  2. 2. Dağdeviren T. Peri-implantasyon döneminde sıçan endometriumunda wnt-β katenin yolağının TCF, lef ve caspase-9 ekspresyonundaki rolü. 2019.
  3. 3. Nusse R. Wnt signaling in disease and in development. Cell Res. 2005;15(1):28-32. doi: 10.1038/sj.cr.7290260.
  4. 4. Miller JR, Hocking AM, Brown JD, Moon RT. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene. 1999;18(55):7860-7872. doi: 10.1038/sj.onc.1203245.
  5. 5. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15):1837-1851.
  6. 6. Moon RT, Kohn AD, De Ferrari GV, Kaykas A. WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004;5(9):691-701. doi: 10.1038/nrg1427.
  7. 7. Miller JR. The Wnts. Genome Biol. 2002;3(1):REVIEWS3001. doi: 10.1186/gb-2001-3-1-reviews3001.
  8. 8. Mikels AJ, Nusse R. Wnts as ligands: processing, secretion and reception. Oncogene. 2006;25(57):7461-7468. doi: 10.1038/sj.onc.1210053.

Details

Primary Language

English

Subjects

Histology and Embryology

Journal Section

Research Article

Early Pub Date

August 25, 2024

Publication Date

November 4, 2024

Submission Date

June 29, 2024

Acceptance Date

August 22, 2024

Published in Issue

Year 2024 Volume: 10 Number: 6

AMA
1.Dağdeviren T. RETRACTED - Cell transcription dependent on Wingless-type (Wnt)/beta-catenin in the rat estrous cycle stages. Eur Res J. 2024;10(6):617-625. doi:10.18621/eurj.1506954